Papers
1
Total Citations
6
H-Index
1
About
Dr. Yiping Ning has made significant contributions to urologic oncology, with a particular focus on advancing minimally invasive surgical techniques for testicular cancer. Their most cited work, a 2023 systematic review and meta-analysis, rigorously evaluated the clinical efficacy and safety of robotic retroperitoneal lymph node dissection (RPLND) compared to traditional approaches. This landmark study synthesized evidence to demonstrate that robotic RPLND offers a safe and effective alternative, potentially reducing morbidity while maintaining oncologic control—a critical advancement in the management of testicular tumors. By systematically analyzing outcomes across multiple studies, Dr. Ning provided the urological community with high-quality evidence supporting the adoption of robotic surgery in this complex procedure. Although early in their career, this work has already garnered 6 citations, reflecting its growing influence in shaping surgical practice. Dr. Ning’s research sits at the intersection of surgical innovation and evidence-based medicine, helping to define the role of robotics in urologic oncology. Their contributions are particularly valuable for researchers and clinicians seeking to optimize treatment pathways for testicular cancer patients through less invasive, yet equally effective, surgical interventions.
Research Focus
Key Achievements
Top Papers
- 1